1,643
Views
2
CrossRef citations to date
0
Altmetric
Research Article

A correlation of thrombin generation assay and clot waveform analysis in patients on warfarin

ORCID Icon, , , , , , , , & show all

References

  • Lancé MD. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J. 2015;13(1).https://doi.org/10.1186/1477-9560-13-1.
  • Shima M, Thachil J, Nair SC, et al. Scientific. towards standardization of clot waveform analysis and recommendations for its clinical applications. J Thromb Haemost. 2013;11(7):1417–1420.
  • Siegemund T, Scholz U, Schobess R, et al. Clot waveform analysis in patients with haemophilia A. Hamostaseologie. 2014;34:S48–S62.
  • Toh CH, Giles AR. Waveform analysis of clotting test optical profiles in the diagnosis and management of disseminated intravascular coagulation (DIC). Clin Lab Haematol. 2002;24(6):321–327.
  • Rivard GE, Brummel-Ziedins KE, Mann KG, et al. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost. 2005 Sep;3(9):2039–2043. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2005.01513.x.
  • Schmidt DE, Chaireti R, Bruzelius M, et al. Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients. Thromb Res. 2019;178(February):34–40.
  • Hemker HC, Giesen P, Aldieri R, et al. The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32:249–253.
  • Nogami K, Matsumoto T, Tabuchi Y, et al. Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab. J Thromb Haemostasis. 2018;16(6):1078–1088.
  • Gatt A, Van Veen JJ, Bowyer A, et al. Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation. Br J Haematol. 2008;142(6):946–952.
  • Matsumoto T, Shima M, Takeyama M, et al. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay. J Thromb Haemostasis. 2006;4(2):377–384.
  • Smith SA, Comp PC, Morrissey JH. Phospholipid composition controls thromboplastin sensitivity to individual clotting factors. J Thromb Haemostasis. 2006;4(4):820–827.
  • Kintigh J, Monagle P, Ignjatovic V. A review of commercially available thrombin generation assays. Res Pract Thromb Haemost. 2018;2(1):42–48.
  • Braun PJ, Givens TB, Stead AG, et al. Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thromb Haemostasis. 1997;78(3):1079–1087.
  • Machlus K, Colby E, Wu J, et al. Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thromb Haemost. 2009 Nov 27;102(11):936–944. Available from: http://www.thieme-connect.de/DOI/DOI?10.1160/TH09-03-0180.
  • Watala C, Golanski J, Kardas P. Multivariate relationships between international normalized ratio and vitamin K-dependent coagulation-derived parameters in normal healthy donors and oral anticoagulant therapy patients. Thromb J. 2003;1.